Nonalcoholic fatty liver disease: Risk factors and long-term outcomes for benign versus aggressive disease.

被引：0
|
作者：
Matteoni, CA
Younossi, ZM
Gramlich, T
Liu, Y
Rybicki, L
McCullough, AJ
机构：
[1] Cleveland Clin Fdn, Dept Gastroenterol, Cleveland, OH 44195 USA
[2] Cleveland Clin Fdn, Dept Pathol, Cleveland, OH 44195 USA
[3] Cleveland Clin Fdn, Dept Biostat, Cleveland, OH 44195 USA
[4] Metrohlth Med Ctr, Cleveland, OH USA
来源：
GASTROENTEROLOGY | 1998年 / 114卷 / 04期
关键词：
D O I：
10.1016/S0016-5085(98)85266-9
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
L0408
引用
收藏
页码：A1298 / A1298
页数：1
相关论文
共 50 条
  • [21] Efficacy of long-term ezetimibe therapy in patients with nonalcoholic fatty liver disease
    Park, Hyohun
    Shima, Toshihide
    Yamaguchi, Kanji
    Mitsuyoshi, Hironori
    Minami, Masahito
    Yasui, Kohichiroh
    Itoh, Yoshito
    Yoshikawa, Toshikazu
    Fukui, Michiaki
    Hasegawa, Goji
    Nakamura, Naoto
    Ohta, Mitsuhiro
    Obayashi, Hiroshi
    Okanoue, Takeshi
    JOURNAL OF GASTROENTEROLOGY, 2011, 46 (01) : 101 - 107
  • [22] Efficacy of long-term ezetimibe therapy in patients with nonalcoholic fatty liver disease
    Hyohun Park
    Toshihide Shima
    Kanji Yamaguchi
    Hironori Mitsuyoshi
    Masahito Minami
    Kohichiroh Yasui
    Yoshito Itoh
    Toshikazu Yoshikawa
    Michiaki Fukui
    Goji Hasegawa
    Naoto Nakamura
    Mitsuhiro Ohta
    Hiroshi Obayashi
    Takeshi Okanoue
    Journal of Gastroenterology, 2011, 46 : 101 - 107
  • [23] CARDIOVASCULAR RISK FACTORS IN NONALCOHOLIC FATTY LIVER DISEASE/NONALCOHOLIC STEATOHEPATITIS
    Ivanova, R.
    Gospodinova, M.
    Petrova, J.
    Alexiev, A.
    Denchev, S.
    Mateva, L.
    ATHEROSCLEROSIS, 2014, 235 (02) : E240 - E240
  • [24] Long-term Use of Proton Pump Inhibitors is Associated With An Increased Risk of Nonalcoholic Fatty Liver Disease
    Huang, Hangkai
    Liu, Zhening
    Guo, Yanjun
    Zeng, Yan
    Shen, Shuxia
    Xu, Chengfu
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2024, 58 (03) : 289 - 296
  • [25] Risk for Development of Severe Liver Disease in Lean Patients With Nonalcoholic Fatty Liver Disease: A Long-Term Follow-Up Study
    Hagstrom, Hannes
    Nasr, Patrik
    Ekstedt, Mattias
    Hammar, Ulf
    Stal, Per
    Hultcrantz, Rolf
    Kechagias, Stergios
    HEPATOLOGY COMMUNICATIONS, 2018, 2 (01) : 48 - 57
  • [26] Lipid profiles in nonalcoholic fatty liver disease.
    Adams, LA
    Keach, J
    Lindor, KD
    Angulo, P
    HEPATOLOGY, 2003, 38 (04) : 512A - 512A
  • [27] Long-Term Mortality in Nonalcoholic Fatty Liver Disease: Is Liver Histology of Any Prognostic Significance?
    Angulo, Paul
    HEPATOLOGY, 2010, 51 (02) : 373 - 375
  • [28] Environmental Risk Factors for Liver Cancer and Nonalcoholic Fatty Liver Disease
    VoPham, Trang
    CURRENT EPIDEMIOLOGY REPORTS, 2019, 6 (01) : 50 - 66
  • [29] Environmental Risk Factors for Liver Cancer and Nonalcoholic Fatty Liver Disease
    Trang VoPham
    Current Epidemiology Reports, 2019, 6 : 50 - 66
  • [30] Long-term outcomes of children with Lyme disease.
    Shapiro, ED
    Seltzer, EG
    Gerber, MA
    Cartter, ML
    PEDIATRIC RESEARCH, 1996, 39 (04) : 1094 - 1094
12345